Freshpet, Inc. Reports Third Quarter 2025 Financial Results
| FRESHPET, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited, in thousands, except per share data) | |||||||
| September 30, 2025 | December 31, 2024 | ||||||
| ASSETS | |||||||
| CURRENT ASSETS: | |||||||
| Cash and cash equivalents | $ | 274,591 | $ | 268,633 | |||
| Accounts receivable, net of allowance for doubtful accounts | 64,327 | 68,419 | |||||
| Inventories, net | 69,845 | 80,794 | |||||
| Prepaid expenses | 9,332 | 16,026 | |||||
| Other current assets | 5,456 | 3,126 | |||||
| Total Current Assets | 423,551 | 436,998 | |||||
| Property, plant and equipment, net | 1,112,864 | 1,065,869 | |||||
| Deposits on equipment | 118 | 1,047 | |||||
| Operating lease right of use assets | 66,703 | 3,366 | |||||
| Long term investment in equity securities | 33,446 | 33,446 | |||||
| Deferred tax assets | 77,919 | - | |||||
| Other assets | 30,941 | 34,152 | |||||
| Total Assets | $ | 1,745,542 | $ | 1,574,878 | |||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||
| CURRENT LIABILITIES: | |||||||
| Accounts payable | $ | 30,839 | $ | 39,164 | |||
| Accrued expenses | 41,488 | 56,263 | |||||
| Current operating lease liabilities | 2,155 | 1,322 | |||||
| Current finance lease liabilities | 2,266 | 2,120 | |||||
| Total Current Liabilities | $ | 76,748 | $ | 98,869 | |||
| Convertible senior notes | 396,781 | 395,163 | |||||
| Long term operating lease liabilities | 65,081 | 2,213 | |||||
| Long term finance lease liabilities | 28,527 | 23,273 | |||||
| Total Liabilities | $ | 567,137 | $ | 519,518 | |||
| Commitments and contingencies | - | - | |||||
| STOCKHOLDERS' EQUITY: | |||||||
| Common stock - voting, $0.001 par value, 200,000 shares authorized, 48,807 issued and 48,793 outstanding on September 30, 2025, and 48,716 issued and 48,702 outstanding on December 31, 2024 | 49 | 49 | |||||
| Additional paid-in capital | 1,355,518 | 1,338,160 | |||||
| Accumulated deficit | (176,484 | ) | (281,806 | ) | |||
| Accumulated other comprehensive loss | (422 | ) | (787 | ) | |||
| Treasury stock, at cost - 14 shares on June 30, 2025 and on December 31, 2024 | (256 | ) | (256 | ) | |||
| Total Stockholders' Equity | 1,178,405 | 1,055,360 | |||||
| Total Liabilities and Stockholders' Equity | $ | 1,745,542 | $ | 1,574,878 | |||
| FRESHPET, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (Unaudited in thousands, except per share data) | |||||||||||||||
| For the Three Months Ended September 30, | For the Nine Months Ended September 30, | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| NET SALES | $ | 288,848 | $ | 253,367 | $ | 816,786 | $ | 712,469 | |||||||
| COST OF GOODS SOLD | 174,656 | 151,120 | 490,616 | 428,112 | |||||||||||
| GROSS PROFIT | 114,192 | 102,247 | 326,170 | 284,357 | |||||||||||
| SELLING, GENERAL, AND ADMINISTRATIVE EXPENSES | 89,291 | 90,338 | 294,961 | 265,734 | |||||||||||
| INCOME FROM OPERATIONS | 24,901 | 11,909 | 31,209 | 18,623 | |||||||||||
| OTHER (EXPENSES) INCOME: | |||||||||||||||
| Interest and Other Income, net | 2,356 | 2,963 | 6,948 | 9,158 | |||||||||||
| Interest Expense | (3,552 | ) | (2,923 | ) | (10,761 | ) | (8,734 | ) | |||||||
| Gain on Equity Investment | - | - | - | 9,918 | |||||||||||
| (1,196 | ) | 40 | (3,813 | ) | 10,342 | ||||||||||
| INCOME BEFORE INCOME TAXES | 23,705 | 11,949 | 27,396 | 28,965 | |||||||||||
| INCOME TAX (BENEFIT) EXPENSE | (77,958 | ) | 54 | (77,926 | ) | 162 | |||||||||
| INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS | $ | 101,663 | $ | 11,895 | $ | 105,322 | $ | 28,803 | |||||||
| OTHER COMPREHENSIVE (LOSS) INCOME: | |||||||||||||||
| Change in foreign currency translation | $ | (86 | ) | $ | 604 | $ | 365 | $ | 407 | ||||||
| TOTAL OTHER COMPREHENSIVE (LOSS) INCOME | (86 | ) | 604 | 365 | 407 | ||||||||||
| TOTAL COMPREHENSIVE INCOME | $ | 101,577 | $ | 12,499 | $ | 105,687 | $ | 29,210 | |||||||
| NET INCOME PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS | |||||||||||||||
| -BASIC | $ | 2.08 | $ | 0.25 | $ | 2.16 | $ | 0.59 | |||||||
| -DILUTED | $ | 1.86 | $ | 0.24 | $ | 2.00 | $ | 0.57 | |||||||
| WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING | |||||||||||||||
| -BASIC | 48,787 | 48,509 | 48,766 | 48,436 | |||||||||||
| -DILUTED | 55,875 | 50,282 | 55,991 | 50,203 | |||||||||||
| FRESHPET, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited, in thousands) | |||||||
| For the Nine Months Ended September 30, | |||||||
| 2025 | 2024 | ||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||
| Net income | $ | 105,322 | $ | 28,803 | |||
| Adjustments to reconcile net income to net cash flows provided by operating activities: | |||||||
| Provision for loss on accounts receivable | 12,130 | 15 | |||||
| Loss on disposal of property, plant and equipment | 1,355 | 1,054 | |||||
| Share-based compensation | 20,256 | 37,862 | |||||
| Inventory obsolescence | - | 732 | |||||
| Depreciation and amortization | 66,798 | 52,249 | |||||
| Amortization of deferred financing costs | 1,618 | 1,559 | |||||
| Change in operating lease right of use asset | 1,529 | 1,045 | |||||
| Gain on equity investment | - | (9,918 | ) | ||||
| Deferred income taxes | (77,919 | ) | - | ||||
| Changes in operating assets and liabilities: | |||||||
| Accounts receivable | (7,410 | ) | (8,294 | ) | |||
| Inventories | 9,825 | (8,852 | ) | ||||
| Prepaid expenses and other current assets | (3,992 | ) | (803 | ) | |||
| Other assets | 80 | (1,540 | ) | ||||
| Accounts payable | (7,097 | ) | 8,839 | ||||
| Accrued expenses | (15,874 | ) | 2,355 | ||||
| Operating lease liability | (1,166 | ) | (1,187 | ) | |||
| Net cash flows provided by operating activities | 105,455 | 103,919 | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||
| Acquisitions of property, plant and equipment, software and deposits on equipment | (95,134 | ) | (128,828 | ) | |||
| Net cash flows used in investing activities | (95,134 | ) | (128,828 | ) | |||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||
| Tax withholdings related to net shares settlements of restricted stock units | (3,054 | ) | (1,440 | ) | |||
| Principal payments under finance lease obligations | (1,573 | ) | (1,444 | ) | |||
| Proceeds from exercise of options to purchase common stock | 264 | 5,516 | |||||
| Net cash flows (used in) provided by financing activities | (4,363 | ) | 2,632 | ||||
| NET CHANGE IN CASH AND CASH EQUIVALENTS | 5,958 | (22,277 | ) | ||||
| CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR | 268,633 | 296,871 | |||||
| CASH AND CASH EQUIVALENTS, END OF PERIOD | $ | 274,591 | $ | 274,594 | |||
| FRESHPET, INC. AND SUBSIDIARIES RECONCILIATION BETWEEN GROSS PROFIT AND ADJUSTED GROSS PROFIT | |||||||||||||||
| For the Three Months Ended September 30, | For the Nine Months Ended September 30, | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| (Dollars in thousands) | |||||||||||||||
| Gross profit | $ | 114,192 | $ | 102,247 | $ | 326,170 | $ | 284,357 | |||||||
| Depreciation expense | 17,115 | 13,197 | 46,024 | 35,698 | |||||||||||
| Non-cash share-based compensation | 1,503 | 1,610 | 4,617 | 6,451 | |||||||||||
| Loss on disposal of manufacturing equipment | 32 | 639 | 287 | 692 | |||||||||||
| Adjusted Gross Profit | $ | 132,842 | $ | 117,693 | $ | 377,098 | $ | 327,198 | |||||||
| Adjusted Gross Profit as a % of Net Sales | 46.0 | % | 46.5 | % | 46.2 | % | 45.9 | % |
| FRESHPET, INC. AND SUBSIDIARIES RECONCILIATION BETWEEN SG&A EXPENSES AND ADJUSTED SG&A EXPENSES | |||||||||||||||
| For the Three Months Ended September 30, | For the Nine Months Ended September 30, | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| (Dollars in thousands) | |||||||||||||||
| SG&A expenses | $ | 89,291 | $ | 90,338 | $ | 294,961 | $ | 265,734 | |||||||
| Depreciation and amortization expense | 6,535 | 5,512 | 18,639 | 15,967 | |||||||||||
| Non-cash share-based compensation (a) | 3,716 | 10,498 | 15,639 | 31,411 | |||||||||||
| Loss on disposal of equipment | 94 | 129 | 486 | 362 | |||||||||||
| Distributor transition costs (b) | - | - | 10,680 | - | |||||||||||
| Legal obligation (c) | 716 | - | 5,703 | - | |||||||||||
| International business charges (d) | - | - | 1,273 | - | |||||||||||
| Adjusted SG&A Expenses | $ | 78,230 | $ | 74,199 | $ | 242,541 | $ | 217,994 | |||||||
| Adjusted SG&A Expenses as a % of Net Sales | 27.1 | % | 29.3 | % | 29.7 | % | 30.6 | % |
| (a) | Includes true-ups to share-based compensation expense. We have certain outstanding share-based awards with performance-based vesting conditions that require the achievement of certain Adjusted EBITDA margins, Adjusted EBITDA and/or Net Sales targets as a condition of vesting. At each reporting period, we reassess the probability of achieving the performance criteria and the performance period required to meet those targets. When the probability of achieving such performance conditions changes, the compensation cost previously recorded is adjusted as needed. When such performance conditions are deemed to be improbable of achievement, the compensation cost previously recorded is reversed. |
| (b) | Represents a non-recurring loss as a result of an accounts receivable write-off in connection with the liquidation of one of our pet specialty distributors. Concurrent with its liquidation, we transitioned to a new distribution partner, who is a leading pet specialty distributor and who we anticipate will facilitate sales to pet specialty stores. Thus, despite the transitory impact during the first quarter of 2025, our ability to continue to generate sales is consistent with what we would expect to generate within the pet specialty channel. |
| (c) | Represents the net settlement charges for all claims related to the litigation with Phillips. |
| (d) | Represents termination costs due to a business change in our international go-to-market strategy. |
| FRESHPET, INC. AND SUBSIDIARIES RECONCILIATION BETWEEN NET INCOME AND ADJUSTED EBITDA | |||||||||||||||
| For the Three Months Ended September 30, | For the Nine Months Ended September 30, | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| (Dollars in thousands) | |||||||||||||||
| Net income | $ | 101,663 | $ | 11,895 | $ | 105,322 | $ | 28,803 | |||||||
| Depreciation and amortization | 23,650 | 18,709 | 64,663 | 51,665 | |||||||||||
| Interest expense, net of interest income | 1,194 | (40 | ) | 3,803 | (424 | ) | |||||||||
| Income tax (benefit) expense | (77,958 | ) | 54 | (77,926 | ) | 162 | |||||||||
| EBITDA | 48,549 | 30,618 | 95,862 | 80,206 | |||||||||||
| Non-cash share-based compensation (a) | 5,219 | 12,108 | 20,256 | 37,862 | |||||||||||
| Loss on disposal of property, plant and equipment | 126 | 768 | 773 | 1,054 | |||||||||||
| Distributor transition costs (b) | - | - | 10,680 | - | |||||||||||
| Legal obligation (c) | 716 | - | 5,703 | - | |||||||||||
| International business charges (d) | - | - | 1,273 | - | |||||||||||
| Gain on equity investment | - | - | - | (9,918 | ) | ||||||||||
| Adjusted EBITDA | $ | 54,610 | $ | 43,494 | $ | 134,547 | $ | 109,204 | |||||||
| Adjusted EBITDA as a % of Net Sales | 18.9 | % | 17.2 | % | 16.5 | % | 15.3 | % |
| (a) | Includes true-ups to share-based compensation expense. We have certain outstanding share-based awards with performance-based vesting conditions that require the achievement of certain Adjusted EBITDA margins, Adjusted EBITDA and/or Net Sales targets as a condition of vesting. At each reporting period, we reassess the probability of achieving the performance criteria and the performance period required to meet those targets. When the probability of achieving such performance conditions changes, the compensation cost previously recorded is adjusted as needed. When such performance conditions are deemed to be improbable of achievement, the compensation cost previously recorded is reversed. |
| (b) | Represents a non-recurring loss as a result of an accounts receivable write-off in connection with the liquidation of one of our pet specialty distributors. Concurrent with its liquidation, we transitioned to a new distribution partner, who is a leading pet specialty distributor and who we anticipate will facilitate sales to pet specialty stores. Thus, despite the transitory impact during the first quarter of 2025, our ability to continue to generate sales is consistent with what we would expect to generate within the pet specialty channel. |
| (c) | Represents the net settlement charges for all claims related to the litigation with Phillips. |
| (d) | Represents termination costs due to a business change in our international go-to-market strategy. |

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment